Yukio Nakajima
- Hepatology top 0.2%
- Epidemiology top 2%
- Surgery top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Kunio OkudaKunihiko OhnishiNobuo OkazakiToshio OhtsukiHiroshi ObataHiroshi HasegawaMasahiko TomimatsuHirotaka Musha
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (7 papers)Liver Disease and Transplantation (7 papers)Liver Disease Diagnosis and Treatment (5 papers)
- Journals
- GastroenterologyHepatologyCancer
- Partner nations
- JapanUnited States
In The Last Decade
Yukio Nakajima
19 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Hepatology 2.2k
- Epidemiology 1.3k
- Surgery 1.0k
- Oncology 469
- Pulmonary and Respiratory Medicine 427
Countries citing papers authored by Yukio Nakajima
This map shows the geographic impact of Yukio Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukio Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukio Nakajima more than expected).
Fields of papers citing papers by Yukio Nakajima
This network shows the impact of papers produced by Yukio Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukio Nakajima. The network helps show where Yukio Nakajima may publish in the future.
Co-authorship network of co-authors of Yukio Nakajima
This figure shows the co-authorship network connecting the top 25 collaborators of Yukio Nakajima. A scholar is included among the top collaborators of Yukio Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukio Nakajima. Yukio Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 5 | |
| 3 | 81 | |
| 4 | Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsbreakdown → | 1554 |
| 5 | 175 | |
| 6 | 59 | |
| 7 | Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Observations in ten patients. | 74 |
| 8 | 157 | |
| 9 | An unusual portal-systemic shunt, most likely through a patent ductus venosus -A case report- | 2 |
| 10 | 11 | |
| 11 | 11 | |
| 12 | Lethal effect of aclacinomycin A on cultured mouse L cells. | 5 |
| 13 | Enhancement of mammalian cell killing by 5-fluorouracil in combination with X-rays. | 73 |
| 14 | 133 | |
| 15 | 202 | |
| 16 | 22 | |
| 17 | 63 | |
| 18 | 76 | |
| 19 | 121 |
About Yukio Nakajima
Yukio Nakajima is a scholar working on Hepatology, Toxicology and Epidemiology, having authored 19 papers that have together received 2.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease and Transplantation (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (2.2k citations), Epidemiology (1.3k citations) and Cancer Research (381 citations). Yukio Nakajima has collaborated with scholars based in Japan and United States. Frequent co-authors include Kunio Okuda, Kunihiko Ohnishi, Nobuo Okazaki, Toshio Ohtsuki, Hiroshi Obata, Hiroshi Hasegawa, Masahiko Tomimatsu, Hirotaka Musha, Toshiro Nakashima and Yasuhiko Kubo. Their work appears in journals such as Gastroenterology, Hepatology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.